Showing 2,701 - 2,720 results of 3,189 for search '"vaccination"', query time: 0.20s Refine Results
  1. 2701

    Recurrent Herpetic Stromal Keratitis in Mice: A Model for Studying Human HSK by Patrick M. Stuart, Tammie L. Keadle

    Published 2012-01-01
    “…We will document both differences and similarities that derive from this fundamental difference in these models with an eye towards possible vaccines and therapies that demonstrate promise in treating HSK.…”
    Get full text
    Article
  2. 2702

    The power of health economics and outcomes research (HEOR) in making decisions that matter by Oscar Herrera Restrepo

    Published 2021-12-01
    “… Deciding on approving and granting market access to new medical technologies such as pharmaceutical products, vaccines, or medical devices is a multifactorial research problem. …”
    Get full text
    Article
  3. 2703

    Beyond Bell's Palsy: Cephalic Tetanus Unveiled by Lubna Khan, Samra Mansoori, Raeda Khan, Mohammad Iqbal

    Published 2025-01-01
    “… Tetanus, although rare in vaccinated regions, remains common in developing countries. …”
    Get full text
    Article
  4. 2704

    Immune aging and infectious diseases by Ruochan Chen, Ju Zou, Jiawang Chen, Ling Wang, Rui Kang, Daolin Tang, Sihan Zhou, Xiuyuan Hao

    Published 2024-12-01
    “…These changes would impair defense mechanisms, increase susceptibility to infections and reduce vaccine efficacy in older adults. Cellular senescence exacerbates these issues by releasing pro-inflammatory factors, further perpetuating chronic inflammation. …”
    Get full text
    Article
  5. 2705

    The Immune Response to Tumors as a Tool toward Immunotherapy by F. Pandolfi, R. Cianci, D. Pagliari, F. Casciano, C. Bagalà, A. Astone, R. Landolfi, C. Barone

    Published 2011-01-01
    “…Immunotherapy of tumors has developed several techniques: immune cell transfer, vaccines, immunobiological molecules such as monoclonal antibodies that improve the immune responses to tumors. …”
    Get full text
    Article
  6. 2706

    Immunogenetic Factors Associated with Severe Respiratory Illness Caused by Zoonotic H1N1 and H5N1 Influenza Viruses by Jennifer Juno, Keith R. Fowke, Yoav Keynan

    Published 2012-01-01
    “…By better defining the role of genetic variability in influenza infection and identifying key polymorphisms that impair the host immune response or correlate with protection, we will be able to better identify at-risk populations and new targets for therapeutic interventions and vaccines. This paper will summarize known immunogenetic factors associated with susceptibility or severity of both pH1N1 and H5N1 infections and will also identify genetic pathways and polymorphisms of high relevance for future study.…”
    Get full text
    Article
  7. 2707

    Imaging Early Steps of Sindbis Virus Infection by Total Internal Reflection Fluorescence Microscopy by Youling Gu, Yuanzheng Yang, Yuechueng Liu

    Published 2011-01-01
    “…Sindbis virus (SINV) is an alphavirus that has a broad host range and has been widely used as a vector for recombinant gene transduction, DNA-based vaccine production, and oncolytic cancer therapy. …”
    Get full text
    Article
  8. 2708

    Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery by Wei Wang, Kepan Chen, Ting Jiang, Yiyang Wu, Zheng Wu, Hang Ying, Hang Yu, Jing Lu, Jinzhong Lin, Defang Ouyang

    Published 2024-12-01
    “…Abstract Lipid nanoparticles (LNPs) have proven effective in mRNA delivery, as evidenced by COVID-19 vaccines. Its key ingredient, ionizable lipids, is traditionally optimized by inefficient and costly experimental screening. …”
    Get full text
    Article
  9. 2709

    Molecular characteristics and pathogenicity analysis of infectious laryngotracheitis virus isolated in China from 2015 to 2019 by Xuehui Zhang, Lihua Tang, Linqing Duan, Ruihua Yang, Kangchengyin Liu, Jing Zhao, Ye Zhao, Guozhong Zhang

    Published 2025-02-01
    “…Phylogenetic analysis showed that six isolates (SD2015, GD2017, SYB2018, HB201812, HB201806, and TJ2019) were classified together with CEO vaccine strains, while only one isolates LN2018 belonged to the wild-type cluster. …”
    Get full text
    Article
  10. 2710

    Protein-Protein Interactions Inferred from Domain-Domain Interactions in Genogroup II Genotype 4 Norovirus Sequences by Chuan-Ching Huang, Chuan Yi Tang

    Published 2013-01-01
    “…However, no efficient vaccine for NoVs exists because of their variable genome sequences. …”
    Get full text
    Article
  11. 2711

    Canine circovirus: an emerging virus of dogs and wild canids by Farzad Beikpour, Arash Letafati, Zahra Ahmadi Fakhr, Nicoal Decaro, Sayed-Hamidreza Mozhgani

    Published 2025-02-01
    “…Prevention strategies are hindered by the lack of targeted vaccines and the virus's resilience in the environment. …”
    Get full text
    Article
  12. 2712

    A symbiotic mosquito‐gut bacterium for flavivirus control by Jinglin Wang, Yibin Zhu, Jun Leng, Yulin Yuan, Yingyi Cao, Gong Cheng, Xueshan Xia

    Published 2024-12-01
    “…However, current measures, including vaccines and treatments, are often limited or ineffective. …”
    Get full text
    Article
  13. 2713

    Strategies to Overcome Antileishmanial Drugs Unresponsiveness by Shyam Sundar, Anup Singh, Om Prakash Singh

    Published 2014-01-01
    “…In the absence of effective vector control measures and vaccines against leishmaniasis, effective chemotherapy remains the mainstay of treatment. …”
    Get full text
    Article
  14. 2714

    Antivirals for the treatment of mild and moderate COVID-19 in South Africa by R Perumal, V Naidoo, S Govender, T N Gengiah

    Published 2023-12-01
    “… While the majority of COVID‐19 cases in South Africa (SA) are mild, patients with severe COVID‐19 requiring hospitalisation present with significant morbidity and mortality and place a substantial burden on healthcare services. Given the low vaccine uptake in SA and other low‐ and middle‐income countries in sub‐Saharan Africa, the high prevalence of comorbidities and limited healthcare system capacity, evidence‐based interventions that reduce the risk of severe disease and death should be considered for implementation. …”
    Get full text
    Article
  15. 2715

    Large-scale screening of HIV-1 T-cell epitopes restricted by 12 prevalent HLA-A allotypes in Northeast Asia and universal detection of HIV-1-specific CD8+ T cells by Yan Ding, Jialai Yan, Ling Huang, Jinhong Yu, Yandan Wu, Chuanlai Shen, Anning Fang

    Published 2025-02-01
    “…BackgroundAlthough the immune response of host T cells to human immunodeficiency virus (HIV) significantly influences the progression of the infection, the development of T-cell-based vaccines and therapies, as well as the clinical evaluation of specific T-cell functions, is currently markedly hindered by the absence of broad-spectrum, functionally validated HIV T-cell epitopes that account for the polymorphisms of the human leukocyte antigen (HLA) within an indicated geographic population. …”
    Get full text
    Article
  16. 2716

    Immunization with OPN5 increased seasonal degradation of reproductive activity in Magang ganders by Jianqiu Pan, Xu Shen, Hongjia Ouyang, Junfeng Sun, Sui Liufu, Danli Jiang, Wenjun Chen, Siyue Peng, Danning Xu, Yunbo Tian, Yunmao Huang, Jianhua He

    Published 2025-02-01
    “…On days 0, 15 and 30, ganders in the immunized group were immunized with OPN5-KLH protein vaccine, and ganders in the control were immunized with the same amount of blank emulsified vaccine. …”
    Get full text
    Article
  17. 2717
  18. 2718
  19. 2719
  20. 2720